Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Vomiting and TYMS[original query] |
---|
Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. Investigational new drugs 2011 Oct 29 (5): 1057-65. Weekes Colin D, Nallapareddy Sujatha, Rudek Michelle A, Norris-Kirby Alexis, Laheru Daniel, Jimeno Antonio, Donehower Ross C, Murphy Kathleen M, Hidalgo Manuel, Baker Sharyn D, Messersmith Wells |
The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population. Avicenna journal of medical biotechnology 0 12 (3): 157-164. Abbasian Mohammad Hadi, Ansarinejad Nafiseh, Abbasi Bahareh, Iravani Masoud, Ramim Tayeb, Hamedi Fahime, Ardekani Ali |
DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of chemotherapy (Florence, Italy) 2022 Sep 1-10. Khalij Yassine, Belaid Imtinen, Chouchane Sana, Amor Dorra, Omezzine Asma, Ben Rejeb Nabila, Ben Ahmed Slim, Bouslama A |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: